Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
39%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
39%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 17.0% | 15.6% | 15.6% | |
| ASTRAZENECA PLC-SPONS ADR | 5.2% | 5.2% | 5.2% | |
| ABBVIE INC | 8.7% | 4.8% | 4.8% | |
| AMGEN INC | 3.9% | 7.3% | 3.9% | |
| PFIZER INC | 3.4% | 4.9% | 3.4% | |
MEDX Overweight Relative to THNR
| NOVARTIS AG-ADR | 6.4% | |
| ALNYLAM PHARMACEUTICALS INC | 5.7% | |
| IONIS PHARMACEUTICALS, INC. | 5.1% | |
| JOHNSON & JOHNSON | 4.9% | |
| BRISTOL-MYERS SQUIBB CO | 4.4% | |
| ABBVIE INC | 3.9% | |
| ALKERMES PLC | 3.4% | |
| CRISPR THERAPEUTICS AG | 3.0% | |
| BIOGEN IDEC INC | 2.8% | |
| GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
MEDX Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -10.3% | |
| CHUGAI PHARMACEUTICAL CO LTD | -7.3% | |
| ROCHE HOLDING LTD | -5.4% | |
| REGENERON PHARMACEUTICALS | -5.3% | |
| INNOVENT BIOLOGICS, INC. | -4.5% | |
| SHIONOGI & CO LTD | -4.4% | |
| CHINA PHARMACEUTICAL GROUP | -3.6% | |
| HIMS & HERS HEALTH, INC. CLASS A | -3.5% | |
| AMGEN INC | -3.4% | |
| ZEALAND PHARMA A/S | -3.2% |